SANTA CLARA, Calif., Oct. 21 /PRNewswire-FirstCall/ -- Applied Imaging
Corp. (Nasdaq: AICX) today announced that it has received an additional U.S.
patent for the detection of objects of interest through the analysis of
multiple microscopic images. Representative objects of interest include rare
cancer cells in tissue and blood, or fetal cells in circulating maternal
blood. This patent further protects techniques developed by the Company and
available in its clinical imaging systems to detect and analyze these targeted
cells using brightfield or fluorescence microscopy.
The specific technology protected by this patent enables the analysis of
multiple cellular proteins or genes within a cell. Combinations of protein
and gene expression test results are emerging as required parameters when
assessing the precise nature of a number of diseases, including cancer.
"We are very pleased to have received our fifth U.S. patent protecting
technologies that we believe are central to the determination of the results
of advanced cellular assays," stated Applied Imaging CEO Carl Hull. "Many of
these innovative techniques have been incorporated in our Ariol(TM) automated
imaging system and allow researchers to perform rapid, multiparametric
analyses of proteins or genes that may be present in samples containing
circulating tumor cells, as one example.
"With this patent, we are further extending our technological lead in the
identification and precise characterization of cells that have potential
clinical relevance," concluded Mr. Hull.
Patent Information
U.S. Patent No. 6,633,662 entitled "Identification of Objects of Interest
Using Multiple Illumination Schemes and Finding Overlap of Features in
Corresponding Multiple Images" was issued on October 14, 2003.
About Applied Imaging
Applied Imaging Corp., based in Santa Clara, California, is the leading
supplier of automated imaging systems utilized in genetics and pathology
laboratories throughout the world for the analysis of chromosomes in cancer
and prenatal disorders. The Company markets a range of imaging systems for
fluorescence and brightfield microscopy applications, including the Company's
Ariol(TM), MDS(TM), SPOT(TM), CytoVision(R), PowerGene(R) and QUIPS(R) product
lines. Applied Imaging has installed in excess of 3,000 systems in over
1,000 laboratories in more than 60 countries.
For additional information on Applied Imaging, visit the Company's Web
site at http://www.aicorp.com.
SOURCE Applied Imaging Corp.
 back to top
Related links:
http://www.aicorp.com
CONTACT:
Barry Hotchkies, CFO of Applied Imaging
Corp., +1-408-562-0250; or Jocelyn Hunter of FRB/Weber Shandwick,
+1-415-248-3433, for Applied Imaging
|
